These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37879779)

  • 1. Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives.
    Nielsen SK; Hansen FG; Rasmussen TB; Fischer T; Lassen JF; Madsen T; Møller DS; Klausen IC; Brodersen JB; Jensen MSK; Mogensen J
    J Am Coll Cardiol; 2023 Oct; 82(18):1751-1761. PubMed ID: 37879779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major Cardiac Events in Patients and Relatives With Hereditary Hypertrophic Cardiomyopathy.
    Nielsen SK; Hansen FG; Rasmussen TB; Fischer T; Lassen JF; Madsen T; Møller DS; Klausen IC; Jensen MSK; Mogensen J
    JACC Adv; 2023 Oct; 2(8):100604. PubMed ID: 38938358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.
    Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP
    Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
    Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
    Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy in children.
    Moak JP; Kaski JP
    Heart; 2012 Jul; 98(14):1044-54. PubMed ID: 22591735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
    Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
    J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.
    Harris S; Cirino AL; Carr CW; Tafessu HM; Parmar S; Greenberg JO; Szent-Gyorgyi LE; Ghazinouri R; Glowny MG; McNeil K; Kaynor EF; Neumann C; Seidman CE; MacRae CA; Ho CY; Lakdawala NK
    Mol Genet Genomic Med; 2019 Nov; 7(11):e940. PubMed ID: 31482667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup.
    Ko C; Arscott P; Concannon M; Saberi S; Day SM; Yashar BM; Helms AS
    Genet Med; 2018 Jan; 20(1):69-75. PubMed ID: 28640247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
    Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
    Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.
    Gaertner-Rommel A; Tiesmeier J; Jakob T; Strickmann B; Veit G; Bachmann-Mennenga B; Paluszkiewicz L; Klingel K; Schulz U; Laser KT; Karger B; Pfeiffer H; Milting H
    Mol Genet Genomic Med; 2019 Aug; 7(8):e841. PubMed ID: 31293105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
    Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
    J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic diagnosis of familial hypertrophic cardiomyopathy: Results in pediatric cardiology.
    Cardoso B; Gomes I; Loureiro P; Trigo C; Ferreira Pinto F
    Rev Port Cardiol; 2017 Mar; 36(3):155-165. PubMed ID: 28214152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.
    Jensen MK; Havndrup O; Christiansen M; Andersen PS; Diness B; Axelsson A; Skovby F; Køber L; Bundgaard H
    Circulation; 2013 Jan; 127(1):48-54. PubMed ID: 23197161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
    van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
    Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Genetic Investigations of 109 Index Patients With Dilated Cardiomyopathy and 445 of Their Relatives.
    Hey TM; Rasmussen TB; Madsen T; Aagaard MM; Harbo M; Mølgaard H; Nielsen SK; Haas J; Meder B; Møller JE; Eiskjær H; Mogensen J
    Circ Heart Fail; 2020 Oct; 13(10):e006701. PubMed ID: 33019804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.